You are here: Home » Reuters » News
Business Standard

Exclusive: EU regulators to clear $62 billion Takeda, Shire deal: source

Reuters  |  BRUSSELS 

(Reuters) - EU antitrust regulators are set to approve Japanese drugmaker Pharmaceutical's $62-billion offer for peer on condition that sells a drug it has in development, a person familiar with the matter said on Friday.

Last month, offered to divest Shire's pipeline compound SHP647 along with some associated rights after the voiced concerns about the overlap with its own drug for

(Reporting by Foo Yun Chee)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, November 09 2018. 22:09 IST